Search

everythinglearnresearchcommunity

for

Search:↓

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Hair transplants can be a treatment for scarring hair loss if there's good blood flow and no active disease.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Ingrown hairs are a common feature in scarring alopecias due to follicular damage.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Intralesional betamethasone and oral hydroxychloroquine improved hair loss in a woman with frontal fibrosing alopecia.

Trichoscopy effectively diagnoses and monitors cicatricial alopecias, reducing the need for biopsies.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Hepatitis C treatment may cause frontal fibrosing alopecia.

Transplanted hair follicles can resist hair loss from an autoimmune condition better than natural hair.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Topical latanoprost and bimatoprost ophthalmic solutions don't help eyelash growth in patients with alopecia areata.

Leukocyte-rich platelet-rich plasma is safe and can potentially help treat scarring hair loss.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

Hair loss gene found on chromosome 3q26.

Micrografts improve hair density and thickness without side effects.

A fungal infection can look like a different scalp condition in teens, leading to wrong treatment until proper tests are done.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Men with early hair loss have lower vitamin D levels.

Vitamin A may influence hair loss conditions like alopecia, but more research is needed to understand how.